UK-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has confirmed a shortfall in shipments of its COVID-19 vaccine to the European Union, APA reports citing Sputnik.
"AstraZeneca is disappointed to announce a shortfall in planned COVID-19 vaccine shipments to the European Union (EU) despite working tirelessly to accelerate supply," the company said in an official statement published on Friday.
The firm explains that the shortfall is due to " lower-than-expected output from the production process" and added that they are ready to compensate for part of the shortfall with vaccines from the international supply network.
AstraZeneca aims to provide the European Union with 100 million doses in the first half of the year, 30 million of which are due to be delivered in the first quarter.
The COVID-19 vaccine by AstraZeneca has been recently making headlines as a specific batch of the vaccines was linked to blood clot concerns. In a media briefing on Friday, World Health Organisation Director-General Tedros Adhanom Ghebreyesus said that a full investigation was underway.